If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giuseppe Schepisi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
Androgen Receptors Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Germ Cell and Embryonal Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

  • 118 Citations
  • 6 h-Index
  • 15 Article
  • 6 Review article
  • 1 Letter
1 Citation (Scopus)

Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer

Conteduca, V., Castro, E., Wetterskog, D., Scarpi, E., Jayaram, A., Romero-Laorden, N., Olmos, D., Gurioli, G., Lolli, C., Sáez, M. I., Puente, J., Schepisi, G., Salvi, S., Wingate, A., Medina, A., Querol-Niñerola, R., Marin-Aguilera, M., Arranz, J. A., Fornarini, G., Basso, U. & 4 others, Mellado, B., Gonzalez-Billalabeitia, E., Attard, G. & De Giorgi, U., Jul 1 2019, In : European Journal of Cancer. 116, p. 158-168 11 p.

Research output: Contribution to journalArticle

Castration
Androgen Receptors
Prostatic Neoplasms
docetaxel
Disease-Free Survival

Reclassification of good-risk seminoma: Prognostic factors, novel biomarkers and implications for clinical management

Casadei, C., Schepisi, G., Menna, C., Chovanec, M., Gurioli, G., Gallà, V., Altavilla, A., Marcellini, M., Bellia, S. R., Lolli, C., Mego, M., Rosti, G. & De Giorgi, U., Apr 1 2019, In : Future Oncology. 15, 12, p. 1347-1352 6 p.

Research output: Contribution to journalArticle

Seminoma
Biomarkers
Germ Cell and Embryonal Neoplasms
Lung Diseases
Neoplasms

AR copy number and AR signaling-directed therapies in castration-resistant prostate cancer

Salvi, S., Conteduca, V., Lolli, C., Testoni, S., Casadio, V., Zaccheroni, A., Rossi, L., Burgio, S. L., Menna, C., Schepisi, G. & De Giorgi, U., Jan 1 2018, In : Current Cancer Drug Targets. 18, 9, p. 869-876 8 p.

Research output: Contribution to journalReview article

Castration
Androgen Receptors
Prostatic Neoplasms
Therapeutics
Neoplasms

Association among metabolic syndrome, inflammation, and survival in prostate cancer

Conteduca, V., Caffo, O., Galli, L., Maugeri, A., Scarpi, E., Maines, F., Chiuri, V. E., Lolli, C., Kinspergher, S., Schepisi, G., Santoni, M., Santini, D., Fratino, L., Burgio, S. L., Salvi, S., Menna, C. & De Giorgi, U., May 1 2018, In : Urologic Oncology: Seminars and Original Investigations. 36, 5, p. 240.e1-240.e11

Research output: Contribution to journalArticle

Prostatic Neoplasms
Inflammation
Survival
Castration
Blood Sedimentation

Association among metabolic syndrome, inflammation, and survival in prostate cancer

Conteduca, V., Caffo, O., Galli, L., Maugeri, A., Scarpi, E., Maines, F., Chiuri, V. E., Lolli, C., Kinspergher, S., Schepisi, G., Santoni, M., Santini, D., Fratino, L., Burgio, S. L., Salvi, S., Menna, C. & De Giorgi, U., 2018, In : Urologic Oncology: Seminars and Original Investigations. 36, 5, p. 240.e1-240.e11

Research output: Contribution to journalArticle